Sirona Biochem Corp. (CVE:SBM – Get Free Report)’s stock price fell 16.7% during trading on Tuesday . The stock traded as low as C$0.05 and last traded at C$0.05. 113,000 shares were traded during mid-day trading, an increase of 91% from the average session volume of 59,069 shares. The stock had previously closed at C$0.06.
Sirona Biochem Price Performance
The company has a 50 day moving average of C$0.06 and a 200 day moving average of C$0.06. The company has a current ratio of 0.34, a quick ratio of 2.41 and a debt-to-equity ratio of 219.21. The firm has a market cap of C$12.84 million, a price-to-earnings ratio of -5.00 and a beta of -0.03.
Sirona Biochem Company Profile
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
See Also
- Five stocks we like better than Sirona Biochem
- Investing In Automotive Stocks
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What Are the U.K. Market Holidays? How to Invest and Trade
- What Does the Future Hold for Eli Lilly?
- Trading Stocks: RSI and Why it’s Useful
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
